These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15315788)

  • 1. Myeloma cells (5TMM) and their interactions with the marrow microenvironment.
    Menu E; Asosingh K; Van Riet I; Croucher P; Van Camp B; Vanderkerken K
    Blood Cells Mol Dis; 2004; 33(2):111-9. PubMed ID: 15315788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration, adhesion and differentiation of malignant plasma cells in the 5T murine model of myeloma.
    Asosingh K
    Verh K Acad Geneeskd Belg; 2003; 65(2):127-34. PubMed ID: 12870183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5T2MM murine model of multiple myeloma: maintenance and analysis.
    Vanderkerken K; Asosingh K; Willems A; De Raeve H; Couck P; Gorus F; Croucher P; Van Camp B
    Methods Mol Med; 2005; 113():191-205. PubMed ID: 15968104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model.
    Menu E; Asosingh K; Indraccolo S; De Raeve H; Van Riet I; Van Valckenborgh E; Vande Broek I; Fujii N; Tamamura H; Van Camp B; Vanderkerken K
    Haematologica; 2006 May; 91(5):605-12. PubMed ID: 16627256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique pathway in the homing of murine multiple myeloma cells: CD44v10 mediates binding to bone marrow endothelium.
    Asosingh K; Günthert U; De Raeve H; Van Riet I; Van Camp B; Vanderkerken K
    Cancer Res; 2001 Apr; 61(7):2862-5. PubMed ID: 11306459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma biology: lessons from the 5TMM models.
    Vanderkerken K; Asosingh K; Croucher P; Van Camp B
    Immunol Rev; 2003 Aug; 194():196-206. PubMed ID: 12846816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homing mechanisms in the biology of multiple myeloma.
    Van Camp B; Van Riet I
    Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homing mechanisms in the etiopathogenesis of multiple myeloma.
    Van Riet I; Bakkus M; De Greef C; Faid L; Van Camp B
    Stem Cells; 1995 Aug; 13 Suppl 2():22-7. PubMed ID: 8520507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma.
    Asosingh K; Menu E; Van Valckenborgh E; Vande Broek I; Van Riet I; Van Camp B; Vanderkerken K
    Clin Exp Metastasis; 2002; 19(7):583-91. PubMed ID: 12498387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
    Vanderkerken K; Medicherla S; Coulton L; De Raeve H; Willems A; Lawson M; Van Camp B; Protter AA; Higgins LS; Menu E; Croucher PI
    Cancer Res; 2007 May; 67(10):4572-7. PubMed ID: 17495322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homing mechanisms of myeloma cells.
    Van Riet I
    Pathol Biol (Paris); 1999 Feb; 47(2):98-108. PubMed ID: 10192876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nuclear factor kappaB on angiogenesis regulation through monocyte chemotactic protein-1 in myeloma.
    Stifter S
    Med Hypotheses; 2006; 66(2):384-6. PubMed ID: 16253428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo homing and differentiation characteristics of mature (CD45-) and immature (CD45+) 5T multiple myeloma cells.
    Asosingh K; De Raeve H; Croucher P; Goes E; Van Riet I; Van Camp B; Vanderkerken K
    Exp Hematol; 2001 Jan; 29(1):77-84. PubMed ID: 11164108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of 5T33 myeloma cells in the C57BL/KaLwRij mouse: establishment of a new syngeneic murine model of multiple myeloma.
    Alici E; Konstantinidis KV; Aints A; Dilber MS; Abedi-Valugerdi M
    Exp Hematol; 2004 Nov; 32(11):1064-72. PubMed ID: 15539084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
    Hecht M; Heider U; Kaiser M; von Metzler I; Sterz J; Sezer O
    Br J Haematol; 2007 Aug; 138(4):446-58. PubMed ID: 17593251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
    Nguyen AN; Stebbins EG; Henson M; O'Young G; Choi SJ; Quon D; Damm D; Reddy M; Ma JY; Haghnazari E; Kapoun AM; Medicherla S; Protter A; Schreiner GF; Kurihara N; Anderson J; Roodman GD; Navas TA; Higgins LS
    Exp Cell Res; 2006 Jun; 312(10):1909-23. PubMed ID: 16600214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells.
    Vincent L; Jin DK; Karajannis MA; Shido K; Hooper AT; Rashbaum WK; Pytowski B; Wu Y; Hicklin DJ; Zhu Z; Bohlen P; Niesvizky R; Rafii S
    Cancer Res; 2005 Apr; 65(8):3185-92. PubMed ID: 15833849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment.
    Mitsiades CS; Mitsiades NS; Richardson PG; Munshi NC; Anderson KC
    J Cell Biochem; 2007 Jul; 101(4):950-68. PubMed ID: 17546631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse.
    Vanderkerken K; De Greef C; Asosingh K; Arteta B; De Veerman M; Vande Broek I; Van Riet I; Kobayashi M; Smedsrod B; Van Camp B
    Br J Cancer; 2000 Feb; 82(4):953-9. PubMed ID: 10732771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.